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ABSTRACT 
Decellularization of skeletal muscle is a process that removes cellular components of 
skeletal muscle tissue while leaving behind the intact extracellular matrix (ECM). 
Skeletal muscle ECM is currently being studied as a biologic scaffold for repairing 
volumetric muscle loss (VML) because the removal of cells greatly reduces the 
antigenicity of the donor tissue. Decellularization usually relies on passive diffusion of 
detergents, surfactants and/or osmotic solutions to strip cells from the ECM. However, 
passive diffusion alone is usually not sufficient for complete removal of cells from the 
interior of large pieces of skeletal muscle using detergents, such as sodium dodecyl 
sulfate (SDS). The goal of this study was to develop a device that not only removes 
cells by perfusion from the interior of skeletal muscle, but also monitors the progress of 
decellularization in real-time. The device, based around a Raspberry Pi, is a stand-
alone system that does not require a desktop computer or expensive software 
packages. Different flow rates (0.1, 1.0 and 10 mL/hr) along with different 
concentrations of SDS (0.2% and 1.0%) were tested. Decellularization progress was 
monitored and logged to an online spreadsheet. The device was found to be capable of 
decellularizing the medial gastrocnemius of a rat in under 10 hours. Complete 
decellularization was validated using fluorescent imaging. Perfusion decellularized 
muscle samples were found to have no significant differences in collagen or sulfated 
glycosaminoglycan (sGAG) content when compared to samples that were decellularized 
using current passive diffusion protocols. The ECM obtained through the use of this 
device is currently being used for the repair of VML in a rat model.  
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INTRODUCTION 
 
The human body is capable of repairing mild to moderate skeletal muscle 
damage.  However, these innate repair mechanisms are not able to repair and 
regenerate large scale volumetric muscle loss (VML)1.  Advances in tissue engineering 
have yielded researchers and physicians a number of treatment options for other 
tissues such as bone and skin2-4.   In contrast, very few options exist for skeletal muscle 
repair, although a number of scaffold-based and cell-based strategies are currently 
being developed3,5,6.  Biologic and synthetic scaffolds have been produced to provide a 
stable environment for cell proliferation and the production of contractile tissue in vitro 
and in vivo. Corona et al. found that a combination of muscle derived cells on an 
acellular scaffold provided the most functional recovery compared to an acellular 
scaffold alone7.  
Scaffolds that are designed for skeletal muscle tissue engineering are not unlike 
scaffolds used for other applications in the body.  They must promote the adhesion and 
proliferation of cells and must provide the engineered tissue with properties similar to 
native tissue.  Scaffold integration with host vascular and nervous networks must take 
place for successful regeneration of skeletal muscle6.  Scaffold-based strategies 
composed of a biologic or synthetic biomaterial which may or may not be seeded with 
cells prior to implantation. Biologic scaffolds include acellular extracellular matrix 
(ECM)7-14,which are derived through the process of decellularization. 
 Decellularization is a process which removes the cellular components from a 
tissue leaving behind the intact ECM15. Decellularized tissue is promising as a biologic 
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scaffold because it retains the biochemical and morphological structure of the native 
ECM while having dramatically lower antigenicity than an allograft because it lacks 
foreign cell antigens15. Decellularization of tissues and whole organs can be 
accomplished through the use of chemical agents such as: surfactants, detergents or 
osmotic solutions8,15. Decellularization has been used to produce whole organ scaffolds 
for the heart16, liver17, lungs18 and kidneys19.  Whole organ decellularization in many 
cases has been achieved through the use of vascular perfusion16-19. The major inlets 
and outlets (arteries and veins) and the capillary network of organs allow for perfusion 
of the entire organ. Skeletal muscle tissue lacks the major arteries and veins that are 
found in whole organs such as the kidneys, heart and liver. Therefore perfusion 
decellularization of skeletal muscle will require the introduction of an inlet port into the 
tissue. Scaffolds composed of decellularized muscle are unique because they retain the 
parallel alignment of the native muscle from which they were obtained and pores for cell 
attachment left by the previous cells9.  Decellularized muscle lacks the antigenicity of an 
allogenic transplant but requires the infiltration of host cells, innervation, and 
revascularization with associated integration into the host vasculature to produce 
functioning myofibers6,20.   
 One detergent that has been used extensively in decellularization is sodium 
dodecyl sulfate(SDS). SDS is an anionic surfactant that removes cells by disrupting the 
phospholipid bilayer of the cell membrane15. Once a cell is lysed, SDS denatures 
proteins within the cells which allows for more complete removal of cellular 
components15. SDS has been used to decellularize whole organs and tissues for use in 
tissue engineering applications, including skeletal muscle11. In addition, SDS was used 
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to successfully decellularize whole organs using a perfusion based method. Although 
SDS has been shown to cause more ECM degradation than other detergents, studies 
have also shown SDS to be more effective at removing DNA from decellularized 
tissues8. 
The device was designed because we found that whole sections of muscle took 
a considerable amount of time compared to other decellularized tissues. Merritt et al. 
discussed injecting muscles with SDS multiple times throughout the day in order to 
increase the rate of decellularization10. The injections were time consuming and require 
considerably more decellularization fluid. Our goal was to develop a device that could 
constantly deliver SDS to a muscle to shorten the time needed to achieve complete 
decellularization, while not negatively affecting the biochemical and morphological 
properties of decellularized muscle. Using a syringe pump to deliver SDS at known flow 
rates would enable us to compare flow rates and time to complete decellularization. In 
order to quantify the time to decellularization, the device would also need to be capable 
of real-time monitoring of decellularization progress.  
The macroscopic characteristics of muscle and decellularized muscle were used 
to design the monitoring component of this device. Muscle is opaque and pinkish red in 
color while decellularized muscle is much more transparent and white in color. 
Myoglobin, an oxygen-binding protein found within muscle cells, is responsible for the 
pinkish red color seen in intact muscle. As cells are lysed by SDS, the myoglobin is 
flushed out of the remaining ECM along with other intracellular molecules. As the tissue 
approaches complete decellularization, the amount myoglobin and other molecules that 
absorb light reaches a minimum. Once all cellular components are removed, the 
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macroscopic and optical properties of the decellularized muscle remain constant and 
the tissue can be assumed to be decellularized. Characterization of the perfusion 
decellularized muscle with fluorescent labelling was used to validate claims of complete 
decellularization. Biochemical assays were performed to quantify and compare the ECM 
produced by the device to ECM derived through current decellularization protocols. 
 
METHODS 
 
Spectral Properties of Skeletal Muscle  
An absorbance spectral sweep was performed on rat (Sprague Dawley) 
gastrocnemius muscle samples in order to characterize the optical properties of native 
and decellularized skeletal muscle. The gastrocnemius muscle was selected based on 
its past use in muscle regeneration animal studies; the anticipated area of application 
for this device. All animals used in this study were previously sacrificed as part of an 
unrelated study and stored at -20°C until required for testing. In preparation for testing, 
gastrocnemius muscle samples were dissected, and from each whole muscle sample a 
central core was harvested using a biopsy punch (diameter = 6mm) and trimmed to a 
thickness of 4mm. Cylindrical muscle sample cores were loaded into 96 well plates (one 
sample per well) and incubated in a 1% SDS solution for 24 and 48 hours at room 
temperature following published protocols. Untreated muscle samples were maintained 
as controls (n=3 / sample group). At the prescribed time points, a spectral sweep of 
tissue sample absorbance was measured (400-900nm, step size = 5nm) with the aid of 
a plate reader (Biotek Model, Winooski, VT). For comparison, the absorbance spectra of 
4 
 
myoglobin, an abundant intracellular skeletal muscle protein, were also characterized 
(0.1, 0.3, and 0.6% in phosphate buffered saline). Absorbance versus wavelength data 
for all muscle and myoglobin samples were plotted and examined for the presence of 
decellularization sensitive absorbance peaks 
 
Device Design and Fabrication 
The design goal was to combine continuous tissue perfusion and real time optical 
monitoring into a single bench top decellularization device. The two primary 
components of the device are the muscle perfusion units and optical detection collars 
with integrated data collection hardware and software. The perfusion units, optical 
monitoring collars, and data collection hardware are housed within and mounted onto a 
custom fabricated two piece enclosure (Figure 1). The enclosure was designed to 
accommodate four individual decellularization units each capable of accommodating a 
single muscle tissue sample. The closure also isolates the optical monitoring collars 
from ambient light. Each of the four modular perfusion units consists of a rigid acrylic 
cylinder (ID = 10mm; length = 40mm) which form the translucent perfusion chamber. 
The inlet and outlet of each chamber is enclosed by watertight ports fashioned with Leur 
lock style fitting and fabricated in acrylic with the aid of a 3-D printer (Objet 30, Objet, 
Israel). The inlet port incorporates a removable 26-ga stainless steel hypodermic needle 
(length = 20 mm). The needle is used to deliver decellularization solution deep into the 
interior of individual muscle samples (Figure 2). The flow of decellularization fluid into 
each decellularization unit was controlled via a commerical syringe pump (Model 210, 
Harvard Apparatus, Holliston, MA) capable of delivering fluid to all four chambers over a 
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broad range of flow rates (0.1 to 10ml/hr) that would be evaluated during device 
characterization. Waste decellularization solution is collected in a reservoir for disposal 
or evaluation. 
The optical collar was fitted with a single light emitting diode (LED) producing a 
peak emmitance centered at 535nm. Peak LED wavelength selection was motivated by 
the results of the previously described muscle optical property characterization. The 
light output of the LED is directed across the diameter of the collar. Located opposite to 
the LED emitter, is a light dependent resistor (LDR) detector. The LDR detector 
converts light intensity in photons to resistance in ohms. The optical collar with 
integrated LED and LDR can be positioned along the length of the decellularization unit. 
During decellularization monitoring the collar is positioned over the muscle sample, 
such that the muscle tissue impedes the light path from the LED emitter to the LDR 
detector. Analog voltages collected from the LDR were converted to digital values using 
a 16-bit analog-to-digital converter (ADC) (Adafruit, NYC, NY). A miniaturized single 
board computer (Raspberry Pi Foundation, United Kingdom) was used to power the 
LEDs and to control collection of the digitized LDR voltage signal from the ADC. Custom 
designed software (Python) was created to collect the voltage data and log it to an 
online spreadsheet. Optical data was collected from the LDR every five minutes. The 
complete system, including syringe pump and flat screen monitor, occupies a 0.5m X 
0.5m footprint, a space that is compatible with typical laboratory workbenches. 
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 Perfusion Decellularized Muscle Characterization 
For all device characterization testing, medical gastrocnemius muscle tissue was 
harvested from Sprague Dawley rats and stored at -80°C until needed for testing as 
previously described. Prior to decellularization all muscles were thawed and rinsed 
briefly in DI water to remove any superficial blood or loosely adhered tissue. Whole 
muscle samples were loaded into perfusion chambers, one muscle per chamber, and 
the position was adjusted until the needle tip was visually located at the mid-belly region 
of the muscle. Based on static decellularization pilot testing and guided by published 
methods, muscle samples were perfused using a 1% SDS solution for a duration of 24 
hours at a flow rate of 1ml/hr. Samples (n=4/timepoint) were collected both midway 
through and at the completion of the perfusion treatment. Untreated muscle samples 
were maintained as controls. 
To explore the influence of key perfusion parameters (flow rate and solution 
concentration) on decellularization duration, medial gastrocnemius muscle samples 
were perfused at flow rates of either 0.1, 1, and 10mL/hr using SDS solutions at 
concentration of 0.2 and 1%. A total of 6 parameter combinations were explored (n= 4/ 
parameter condition). Throughout perfusion testing the optical properties of each 
muscle was measured and digitally logged every 5 minutes. The time to sample 
decellularization was recorded as the time at which sample optical properties were 
unchanged (<0.1% difference from the previous recording) for five continuous recording 
(25 minutes). Histological data will be used to validate that tissues are decellularized at 
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this endpoint. For comparison, statically decellularized muscle samples were 
maintained as controls.  
To examine the relationship between muscle optical properties and histological 
appearance, representative untreated control and perfusion treated samples were 
embedded in tissue freezing media (Triangle Biomedical Sciences, Inc., Durham NC), 
sectioned at 8µm with a cryostat, and mounted onto glass microscope slides. Perfused 
treated samples were selected from either the endpoint on the To visualize intracellular 
proteins, mounted sections were immunoreacted for the presence of myoglobin (αrat 
myoglobin, rabbit IgG1, 500:1, Sigma, St. Lous MO) and actin (phalloidin, 40:1, Sigma, 
St. Louis MO) followed by incubation with the appropriate fluorescently labeled 
secondary antibodies (αIgG, 500:1, Invitrogen, Carlsbad, CA). Sections were 
counterstained with the nuclear staining reagent DAPI, and then microscopically imaged 
(Ci-L, Nikon, Troy, NY). Digital images were captured, stored, and examined for the 
presence of intracellular proteins and nuclear remnants. 
To determine whether perfusion decellularization influenced the retention of key 
ECM molecules within treated muscle samples the sulfated glycosaminoglycans 
(sGAG) content for control and perfusion samples was quantified using the procedure 
detailed in Barbosa et al21. Briefly, decellularized muscle samples (control and 
perfusion) were digested in a solution containing 50 µg/mL proteinase K in 100 mM 
K2HPO4 at a pH of 8.0 at 55ºC for 16 hours. The samples were then centrifuged and 
filtered to obtain an extract free of tissue fragments. A 1,9-dimethylmethylene blue 
(DMMB) solution was added to produce an insoluble GAG-DMMB complex. The 
solution was then centrifuged and the supernatant was removed and the GAG-DMMB 
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complex was dissolved with a decomplexation solution. The absorbance of the resulting 
solution was read at 656 nm with the aid of a plate reader (BioTek, Winooski, VT). 
The collagen content for the control and perfusion samples was quantified using 
a hydroxyproline assay. A modified version of the procedure found in Edwards was 
used to analyze collagen content22. Briefly, all tissue samples were hydrolyzed in 6N 
HCl for 16-20 hours at 115ºC. After which, samples were cooled to RT and diluted 1:5 in 
DI water. A buffer composed of citric acid monohydrate, glacial acetic acid, sodium 
acetate, sodium hydroxide, 1-propanol and toluene was prepared according to 
Edwards. Hydroxyproline was dissolved in 100mL of the buffer at this stage to produce 
a hydroxyproline standard. Chloramine-T was dissolved in DI water and in addition to 1-
propanol, was added to the buffer. A second buffer composed of 4-
dimethylaminobenzaldehyde, 1-propanol, and perchloric acid was also prepared. A 
standard dilution was prepared in a 96-well plate and 50 µL of each sample was added 
in triplicate. 100 µL of each buffer was added to each well (samples and standards) and 
the plate was read immediately at 570 nm with the aid of a plate reader (BioTek, 
Winooksi, VT). 
 
RESULTS 
 
Spectral Characterization of Skeletal Muscle 
The absorbance spectral sweep for myoglobin solutions show a decreasing 
absorbance peak with lower concentrations of myoglobin (Figure 4A). The absorbance 
peak is found between 480-550 nm in the 0.6% solution. The absorbance peak of the 
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0.3% myoglobin solution is 58% smaller than the 0.6% solution. The 0.1% solution has 
an absorbance peak that is 85% smaller than the 0.6% myoglobin solution. 
Decellularizing skeletal muscle in 96-well plates provided quantitative data on the 
progress of decellularization in the form of absorbance spectra. A representative sample 
of the absorbance spectra of rat skeletal muscle, partially decellularized muscle and 
decellularized muscle is shown in Figure 4B. An absorbance peak appears around 520-
550 nm in the muscle sample, is present but less pronounced in PDM and absent in 
decellularized muscle. The absorbance peak for the PDM is 37% smaller than the 
absorbance peak of the untreated muscle. Although there appears to be a peak under 
450 nm, the plate reader was unable to produce reliable absorbance data at such small 
wavelengths.  
 
Device Design and Fabrication 
The device performed as designed and produced decellularized muscle samples 
for multiple flow rates and SDS concentrations. Four decellularization chambers were 
housed in the 3D printed box (Figure 3A). The Raspberry Pi microcomputer, ADC, 
GPIO breakout board, and a custom PCB were all mounted to the 3D printed top 
(Figure 3B). The complete assembly of the device was connected to the internet, an 
LCD monitor, and a keyboard and then powered through the Raspberry Pi (Figure 3: C 
& D). The Raspberry Pi with the ADC was sufficient for monitoring the voltage of the 
LDR and the python program was able to reliably upload the data to a log file saved in 
Google spreadsheets. The log file, which could be read in real-time or after the 
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completion of decellularization, provided meaningful data on the decellularization 
progress of four chambers simultaneously. 
 
 
Perfusion Decellularized Muscle Characterization 
The cryosectioned and stained native skeletal muscle tissue samples showed the 
presence of myoglobin, actin and nuclear remnants (Figure 5:A & D) and myofiber 
alignment (Figure 5A). Although nuclear remnants cannot be seen in the midpoint 
decellularized muscle samples, myoglobin and intracellular actin can still be detected 
(Figure 5:B & E). Endpoint decellularized muscle tissue displayed an absence of 
myoglobin, intracellular actin, and nuclear remnants (Figure 5:C & F). Individual 
myofibers can be seen in Figure 5:A & D, however, after partial decellularization the 
intact myofibers are absent in Figures 5:B & E.  
The voltage logs generated by the Python program (Figure 6) provide a 
visualization of decellularization progress. Muscles were determined to be completely 
decellularized when the previous 5 readings had less than 0.1% change. The control 
sample was not included; After one week, the muscle was not completely 
decellularized. At an SDS concentration of 0.2%, the hours to decellularization were 
142.7 ± 7.7, 42.4 ± 3.0, 9.9 ± 1.2 for the flow rates of 0.1 mL/hr, 1.0 mL/hr, and 10 mL/hr 
respectively. While at an SDS concentration of 1.0%, the hours to decellularization were 
107.0 ± 6.5, 35.1 ± 2.5, 7.2 ± 1.0 for the flow rates of 0.1 mL/hr, 1.0 mL/hr, and 10 mL/hr 
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respectively. Although SDS concentration did have a significant effect on time to 
decellularization (Figure 7), the device flow rate had a much greater effect.  
 Perfusion decellularization did not significantly affect collagen or sGAG 
concentration when compared to diffusion decellularized control samples. Regardless of 
flow rate or SDS concentration, none of the samples had significant differences in either 
collagen or sGAG from the control samples (Figure 8). All averages were within 10% of 
the diffusion decellularized control samples and of each other. No trends were observed 
with regard to flow rate or concentration. 
DISCUSSION 
 
This device was primarily developed to decellularize bulky pieces of skeletal 
muscle which are to be used as a template for engineered ECM scaffolds that are being 
created in our lab23. In order to speed up decellularization of bulk skeletal muscle, 
Merritt et al. injected muscle with SDS several times10. We found that bulky skeletal 
muscle, such as MGAS, were not decellularized after up to a week in SDS simply with 
agitation and daily solution changes. The purpose of this device was to provide constant 
injection of SDS into the muscle to increase the rate of decellularization and to reduce 
the amount of man-hours needed for injecting and changing solutions. The placement of 
the needle into the midbelly of the muscle had a great effect on the time to complete 
decellularization and practice was required to achieve consistent positioning and 
results. The time to complete decellularization was greatly decreased by forcing SDS 
out from the inside of the muscle rather than simple diffusion of SDS from the outside of 
the muscle.  
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In addition to decreasing the time to decellularization, this device is also able to 
monitor the progress of decellularization. The macroscopic characteristics of muscle 
and decellularized muscle were used to design the monitoring component. Rat skeletal 
muscle is opaque and pink-red in color while decellularized muscle is much more 
transparent and white in color. By decellularizing muscle in a 96-well plate and obtaining 
an absorbance spectral sweep, we were able to quantify the change from muscle to 
acellular ECM. We observed a local absorbance peak in the 520-550nm range in 
muscle that was not seen in the decellularized muscle and was much less prominent 
but still visible in the partially decellularized muscle (Figure 4). Although the actual 
absorbance value was dependent on the thickness of the tissue, the local peak was 
present in all muscle samples and absent in all decellularized samples. An LED with a 
wavelength of 535 nm was selected for the detection collar to take advantage of the 
absorbance peak. The muscle would therefore absorb less light as decellularization 
progressed. In turn, as more light was transmitted through the tissue, the voltage across 
the LDR would decrease. When the tissue had been completely decellularized, the 
voltage across the LDR changed very little from one reading to the next. When five 
consecutive voltage readings had less than 0.1% change, the sample was considered 
to be decellularized. 
The concentrations of SDS used to test the decellularization device were 1%, as 
is seen in many SDS decellularization protocols, and 0.2%. The lower concentration 
was used as it is below the critical micelle concentration (CMC) for SDS, ~0.225%24. 
The concentration of SDS had a significant effect on the time to decellularization but the 
flow rate had a much larger effect (Figure 7). Although SDS-based protocols have been 
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found to cause significant deterioration of the ECM compared to other detergents and 
decellularization protocols8,25,26, SDS was chosen for this device as it provided a simple 
protocol and has been used in other perfusion based decellularization methods. 
Collagen and sGAG were quantified for all the conditions to determine if perfusion 
based decellularization had a deleterious effect on the acellular ECM. Any advantages 
the perfusion device could provide would be for naught if the system produced 
substandard scaffolds. The biochemical composition of the ECM from the perfused and 
control samples did not differ significantly from one another (Figure 8).  
The detection collar and associated hardware and software allowed us to monitor 
in real-time the progress of the tissue from muscle to acellular ECM. The device was 
originally tested using a desktop computer and National Instruments LabView software 
to log the voltage data from the LDRs. While the device was fully functional and 
performed as designed, the device neither required the computing power of the desktop 
computer nor the robustness of the LabView software package. The Raspberry Pi 
provides internet connectivity, a platform for programming in Python, and a set of GPIO 
pins, all of which were used in this application and allowed the device to operate as a 
stand-alone device. Once the device was set up and connected to the internet using an 
Ethernet cord, the device did not need a monitor, mouse or keyboard as it could be 
accessed using SSH protocol. In addition to starting via the command line, the python 
program could be initiated and shutdown with an SSH client from any smartphone or 
desktop computer with internet connectivity. Logging the voltage data every five minutes 
was sufficient for analyzing decellularization progress without creating an extremely 
large file. 
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This device is novel in its approach to decellularize skeletal muscle and to 
monitor the progress of decellularization. However, there is not a widespread need for 
the ECM processed by this device. Most regenerative medicine strategies for skeletal 
muscle repair involve very thin (<3mm) acellular scaffolds, as host cells do not infiltrate 
much further than that when used to repair skeletal muscle in vivo. Host cell infiltration 
is dependent on angiogenesis within the implanted scaffold6. Even with established or 
nascent vasculature in vitro, without immediate anastomosis with the host’s vasculature, 
cells in the interior of a scaffold will not survive. Until progress is made toward 
angiogenesis and/or revascularization of tissue constructs post-implantation, bulky 
skeletal muscle ECM will not have a translational application. 
Potential refinements to the device include controlling the syringe pump with the 
Raspberry Pi, along with modifications to the enclosure to improve loading of muscles 
into the chambers and to increase the number of chambers that can be housed. If the 
production of acellular ECM needs to be increased, the device can be expanded. The 
device was designed to be modular in that a single chamber could be used or up to four 
chambers, using the current housing, could be run simultaneously. Although the number 
of chambers is limited by the capacity of our current syringe pump, the Raspberry Pi 
and ADC can accommodate eight analog voltage inputs. In addition, other 
decellularization protocols could be adapted for use in this device. Another use for this 
device could also be to recellularize acellular scaffolds by flowing media into the 
midbelly of the scaffold. This would require a much faster flow rates, a peristaltic pump 
instead of a syringe pump, and a separate reservoir for gas exchange within the media. 
Additionally, the device would have to operate in an incubator under sterile conditions.  
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Preliminary trials have begun adapting other decellularization solutions and 
protocols for use in this perfusion driven device. In addition, this device is currently 
being operated to provide skeletal muscle ECM scaffolds which are being used to study 
the repair of VML in a rat model. The perfusion derived skeletal muscle ECM is part of a 
larger investigation into VML repair including comparisons to cell-derived ECM as a 
biologic tissue repair scaffold.  
 
FIGURES 
 
 
 
A B C 
D 
Figure 1: A-C Components of the decellularization chamber as drawn in SolidWorks and 
printed on a 3-D Printer. A. Outlet port. B Inlet port. C Detection collar. D 
Decellularization chamber as designed in SolidWorks, complete with Leur lock 
connectors and 26 ga. needle. 
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A 
D 
C 
B 
Figure 2: A. 26 ga. needle epoxyed into inlet port. B. 
Inlet is connected to syringe pump and needle is 
inserted in muscle. C. Chamber is filled with SDS and 
outlet is connected to waste collector. D. Detector is 
positioned around the muscle. (Photos by Benjamin 
Kasukonis) 
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B A 
C D 
Figure 3: A. Four decellularization chambers inserted in the lower portion of the device. 
B. Top of the device with the Raspberry Pi, ADC, circuit board, and GPIO breakout C. 
Complete assembly of the decellularization device. D. Inside view of the device. (Photos 
by Benjamin Kasukonis 
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Figure 4: A. Absorbance spectra for various concentrations of myoglobin. B. 
Absorbance spectra for representative samples of muscle (M), partially decellularized 
muscle (PDM), and decellularized muscle (DM). 
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Figure 5: 8µm muscle(A,D), midpoint perfusion decellularized muscle(B,E), and 
endpoint perfusion decellularized muscle(C,F) sections stained with phalloidin(red), 
DAPI(blue), and immunostained for myoglobin(green). A-C Longitudinal sections. D-F 
Transverse sections. (Images by Benjamin Kasukonis) 
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 Figure 6: Representitive voltage logs displaying decellularization progress from 0.2% 
SDS perfused samples. 
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21 
 
 Figure 8: A. Collagen content as measured by hydroxyproline assay. B. sGAG content 
as measured by DMMB assay. n=4 for all groups. 
A 
B 
22 
 
REFERENCES 
 
1. Borschel, G.H., Dennis, R.G., and Kuzon, W.M.J. Contractile Skeletal Muscle Tissue-
Engineered on an Acellular Scaffold. Plastic and Reconstructive Surgery 113, 2004.  
2. Bi, H., and Jin, Y.  Current progress of skin tissue engineering: Seed cells, 
bioscaffolds, and construction strategies. Burns and Trauma 1, 63, 2013.  
3. Fisher, M.B., and Mauck, R.L. Tissue engineering and regenerative medicine: recent 
innovations and the transition to translation. Tissue Engineering Part B: Reviews 19, 1, 
2013.  
4. Jayarama Reddy, V., Radhakrishnan, S., Ravichandran, R., Mukherjee, S., 
Balamurugan, R., Sundarrajan, S., and Ramakrishna, S. Nanofibrous structured 
biomimetic strategies for skin tissue regeneration. Wound Repair and Regeneration 21, 
1, 2013.  
5. Juhas, M., Engelmayr, G.C.,Jr, Fontanella, A.N., Palmer, G.M., and Bursac, N. 
Biomimetic engineered muscle with capacity for vascular integration and functional 
maturation in vivo. Proceedings of the National Academy of Sciences of the United 
States of America 111, 5508, 2014.  
6. Turner, N.J., and Badylak, S.F. Regeneration of skeletal muscle. Cell and tissue 
research 347, 759, 2012. 
7. Corona, B.T., Ward, C.L., Baker, H.B., Walters, T.J., and Christ, G.J. Implantation of 
in vitro tissue engineered muscle repair constructs and bladder acellular matrices 
partially restore in vivo skeletal muscle function in a rat model of volumetric muscle loss 
injury. Tissue Engineering Part A 20, 705, 2013. 
8. Gillies, A.R., Smith, L.R., Lieber, R.L., and Varghese, S. Method for decellularizing 
skeletal muscle without detergents or proteolytic enzymes. Tissue Engineering Part C: 
Methods 17, 383, 2010.  
9. Hinds, S., Bian, W., Dennis, R.G., and Bursac, N. The role of extracellular matrix 
composition in structure and function of bioengineered skeletal muscle. Biomaterials 32, 
3575, 2011.  
10. Merritt, E.K., Cannon, M.V., Hammers, D.W., Le, L.N., Gokhale, R., Sarathy, A., 
Song, T.J., Tierney, M.T., Suggs, L.J., Walters, T.J., and Farrar, R.P. Repair of 
traumatic skeletal muscle injury with bone-marrow-derived mesenchymal stem cells 
seeded on extracellular matrix. Tissue Engineering.Part A 16, 2871, 2010.  
23 
 
11. Perniconi, B., Costa, A., Aulino, P., Teodori, L., Adamo, S., and Coletti, D. The pro-
myogenic environment provided by whole organ scale acellular scaffolds from skeletal 
muscle. Biomaterials 32, 7870, 2011.  
12. Valentin, J.E., Turner, N.J., Gilbert, T.W., and Badylak, S.F. Functional skeletal 
muscle formation with a biologic scaffold. Biomaterials 31, 7475, 2010.  
13. Wang, L., Johnson, J.A., Chang, D.W., and Zhang, Q. Decellularized musculofascial 
extracellular matrix for tissue engineering. Biomaterials 34, 2641, 2013.  
14. Wolf, M.T., Daly, K.A., Reing, J.E., and Badylak, S.F. Biologic scaffold composed of 
skeletal muscle extracellular matrix. Biomaterials 33, 2916, 2012.  
15. Gilbert, T.W., Sellaro, T.L., and Badylak, S.F. Decellularization of tissues and 
organs. Biomaterials 27, 3675, 2006.  
16. Ott, H.C., Matthiesen, T.S., Goh, S., Black, L.D., Kren, S.M., Netoff, T.I., and Taylor, 
D.A. Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial 
heart. Nature medicine 14, 213, 2008.  
17. Uygun, B.E., Soto-Gutierrez, A., Yagi, H., Izamis, M., Guzzardi, M.A., Shulman, C., 
Milwid, J., Kobayashi, N., Tilles, A., and Berthiaume, F. Organ reengineering through 
development of a transplantable recellularized liver graft using decellularized liver 
matrix. Nature medicine 16, 814, 2010.  
18. Ott, H.C., Clippinger, B., Conrad, C., Schuetz, C., Pomerantseva, I., Ikonomou, L., 
Kotton, D., and Vacanti, J.P. Regeneration and orthotopic transplantation of a 
bioartificial lung. Nature medicine 16, 927, 2010.  
19. Sullivan, D.C., Mirmalek-Sani, S., Deegan, D.B., Baptista, P.M., Aboushwareb, T., 
Atala, A., and Yoo, J.J. Decellularization methods of porcine kidneys for whole organ 
engineering using a high-throughput system. Biomaterials 33, 7756, 2012.  
20. Levenberg, S., Rouwkema, J., Macdonald, M., Garfein, E.S., Kohane, D.S., 
Darland, D.C., Marini, R., van Blitterswijk, C.A., Mulligan, R.C., and D'Amore, P.A. 
Engineering vascularized skeletal muscle tissue. Nature biotechnology 23, 879, 2005.  
21. Barbosa, I., Garcia, S., Barbier-Chassefiere, V., Caruelle, J.P., Martelly, I., and 
Papy-Garcia, D. Improved and simple micro assay for sulfated glycosaminoglycans 
quantification in biological extracts and its use in skin and muscle tissue studies. 
Glycobiology 13, 647, 2003.  
22. Edwards, C. Modified assay for determination of hydroxyproline in a tissue 
hydrolyzate. Clinica chimica acta 104, 161, 1980. 
24 
 
23. Wolchok, J.C., and Tresco, P.A. The isolation of cell derived extracellular matrix 
constructs using sacrificial open-cell foams. Biomaterials 31, 9595, 2010.  
24. Dominguez, A., Fernandez, A., Gonzalez, N., Iglesias, E., and Montenegro, L. 
Determination of Critical Micelle Concentration of Some Surfactants by Three 
Techniques. Journal of chemical education 74, 1227, 1997.  
25. Faulk, D.M., Carruthers, C.A., Warner, H.J., Kramer, C.R., Reing, J.E., Zhang, L., 
D'Amore, A., and Badylak, S.F. The effect of detergents on the basement membrane 
complex of a biologic scaffold material. Acta biomaterialia 10, 183, 2014.  
26. Keane, T.J., Londono, R., Turner, N.J., and Badylak, S.F. Consequences of 
ineffective decellularization of biologic scaffolds on the host response. Biomaterials 33, 
1771, 2012.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
25 
 
APPENDIX: 
Python program 
#!/usr/bin/python 
 
import time, signal, sys, datetime, gspread 
from Adafruit_ADS1x15 import ADS1x15 
 
#Function from signal library that will end script (Ctrl+C) 
def signal_handler(signal, frame): 
        print 'Session Ended' 
        sys.exit(0) 
signal.signal(signal.SIGINT, signal_handler) 
 
 
ADS1015 = 0x00  # 12-bit ADC 
ADS1115 = 0x01 # 16-bit ADC 
 
# Select the gain 
# gain = 61    # +/- 6.144V 
gain = 4096  # +/- 4.096V 
# gain = 2048  # +/- 2.048V 
# gain = 1024  # +/- 1.024V 
# gain = 512   # +/- 0.512V 
# gain = 256   # +/- 0.256V 
 
# Select the sample rate 
sps = 8    # 8 samples per second 
# sps = 16   # 16 samples per second 
# sps = 32   # 32 samples per second 
# sps = 64   # 64 samples per second 
# sps = 128  # 128 samples per second 
# sps = 250  # 250 samples per second 
# sps = 475  # 475 samples per second 
# sps = 860  # 860 samples per second 
 
# Initialize the ADC using the default mode (use default I2C address) 
adc = ADS1x15(ic=ADS1115) 
 
# Read voltage in single-ended mode using ADS1x15 library 
# volts = adc.readADCSingleEnded(channel, gain, sps) / 1000 
# Example: To read channel 3 in single-ended mode, +/- 1.024V, 860 sps use: 
# volts = adc.readADCSingleEnded(3, 1024, 860) 
 
 
# Define the functions that will be used to query the ADC for voltage 
def read1(): 
     
 volts1 = adc.readADCSingleEnded(0, gain, sps) / 1000 
  
 return volts1 
 
def read2(): 
     
 volts2 = adc.readADCSingleEnded(1, gain, sps) / 1000 
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 return volts2 
 
def read3(): 
     
 volts3 = adc.readADCSingleEnded(2, gain, sps) / 1000 
  
 return volts3 
 
def read4(): 
     
 volts4 = adc.readADCSingleEnded(3, gain, sps) / 1000 
  
 return volts4 
 
print 'Checking account...' 
#Google account details (Redacted for publication) 
email = '******************' 
password = '*********' 
 
 
 
      
#Attempt to log in to google account using supplied credentials 
try: 
    gc = gspread.login(email,password) 
except: 
    print('Login information invalid.') 
    sys.exit() 
print 'Account valid.\n' 
 
#Name of the spreadsheet to be appended 
spreadsheet = 'Decell_Log'  
      
#Open the spreadsheet 
worksheet = gc.open(spreadsheet).sheet1 
print 'Spreadsheet is ready.'      
print "Decellularization logging will begin shortly. To exit, press 
'Ctrl+C'\n"  
      
 
#While loop to read voltages across LDRs and write to the log file 
while True:  
  
#Run the read() function created earlier to write voltages to respective 
variables  
 volts1 = read1() 
 volts2 = read2() 
 volts3 = read3() 
 volts4 = read4()  
  
#Write to the chosen spreadsheet with a timestamp and voltages from the LDRs 
try: 
 values = [datetime.datetime.now(), volts1, volts2, volts3, volts4] 
  worksheet.append_row(values) 
 except: 
  print "Unable to append data." 
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  sys.exit()  
 
#Print values to the CLI  
print datetime.datetime.now(), volts1, volts2, volts3, volts4 
 
#Time delay before next loop iteration (in seconds) 
time.sleep(300)  
 
28 
 
